EMAIL THIS PAGE TO A FRIEND

American journal of physiology. Regulatory, integrative and comparative physiology

Folic acid supplementation during high-fat diet feeding restores AMPK activation via an AMP-LKB1-dependent mechanism.


PMID 26400185

Abstract

AMPK is an endogenous energy sensor that regulates lipid and carbohydrate metabolism. Nonalcoholic fatty liver disease (NAFLD) is regarded as a hepatic manifestation of metabolic syndrome with impaired lipid and glucose metabolism and increased oxidative stress. Our recent study showed that folic acid supplementation attenuated hepatic oxidative stress and lipid accumulation in high-fat diet-fed mice. The aim of the present study was to investigate the effect of folic acid on hepatic AMPK during high-fat diet feeding and the mechanisms involved. Male C57BL/6J mice were fed a control diet (10% kcal fat), a high-fat diet (60% kcal fat), or a high-fat diet supplemented with folic acid (26 mg/kg diet) for 5 wk. Mice fed a high-fat diet exhibited hyperglycemia, hepatic cholesterol accumulation, and reduced hepatic AMPK phosphorylation. Folic acid supplementation restored AMPK phosphorylation (activation) and reduced blood glucose and hepatic cholesterol levels. Activation of AMPK by folic acid was mediated through an elevation of its allosteric activator AMP and activation of its upstream kinase, namely, liver kinase B1 (LKB1) in the liver. Consistent with in vivo findings, 5-methyltetrahydrofolate (bioactive form of folate) restored phosphorylation (activation) of both AMPK and LKB1 in palmitic acid-treated HepG2 cells. Activation of AMPK by folic acid might be responsible for AMPK-dependent phosphorylation of HMG-CoA reductase, leading to reduced hepatic cholesterol synthesis during high-fat diet feeding. These results suggest that folic acid supplementation may improve cholesterol and glucose metabolism by restoration of AMPK activation in the liver.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

L7917 Anti-LKB1 antibody produced in rabbit, IgG fraction of antiserum, buffered aqueous solution
SAB3500366
Anti-LKB1 antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
SAB4502889
Anti-LKB1 antibody produced in rabbit, affinity isolated antibody
SAB4502890
Anti-LKB1 antibody produced in rabbit, affinity isolated antibody
SAB4502888
Anti-LKB1, C-Terminal antibody produced in rabbit, affinity isolated antibody
SAB4504034
Anti-phospho-LKB1 (pSer428) antibody produced in rabbit, affinity isolated antibody
SAB4504035
Anti-phospho-LKB1 (pThr189) antibody produced in rabbit, affinity isolated antibody
SAB1406494
Anti-STK11 antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
HPA017254
Anti-STK11 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
AV41743
Anti-STK11 antibody produced in rabbit, IgG fraction of antiserum, lyophilized powder
H6132
DL-3-Hydroxy-3-methylglutaryl coenzyme A sodium salt hydrate, ≥90% (HPLC)
C27H42N7Na2O20P3S · xH2O
47866
Folic acid, analytical standard
C19H19N7O6
L9168
Monoclonal Anti-LKB1 antibody produced in mouse, ~1 mg/mL, clone Ley37D/G6, purified immunoglobulin, buffered aqueous solution
WH0006794M1 Monoclonal Anti-STK11 antibody produced in mouse, clone 2A7-H2, ascites fluid, buffered aqueous solution